Search
forResearch 10 of 355
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Wound healing in development
- Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries
- Proteomics Characterization of Primary Human Oral Epithelial Cells Using a Novel Culture Technique for Use in Tissue Regeneration
- Urokinase plasminogen activator (uPA) is a positive regulator of outer root sheath keratinocyte proliferation
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- Ku80 as a Novel Receptor for Thymosin β4 That Mediates Its Intracellular Activity Different from G-actin Sequestering
- Urokinase is a Positive Regulator of Epidermal Proliferation In Vivo
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →